2003
DOI: 10.1136/jnnp.74.1.20
|View full text |Cite
|
Sign up to set email alerts
|

The INTERMED: a screening instrument to identify multiple sclerosis patients in need of multidisciplinary treatment

Abstract: Objective: To analyse the value of the INTERMED, a screening instrument to assess case complexity, compared with the Expanded Disability Status Scale (EDSS) and the Guy's Neurological Disability Scale (GNDS) to identify multiple sclerosis (MS) patients in need of multidisciplinary treatment. Methods: One hundred MS patients underwent INTERMED, EDSS, and GNDS examinations. Patient care needs were assessed by a multidisciplinary team and a goal oriented treatment plan was defined. Correlations between INTERMED, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
21
0
4

Year Published

2004
2004
2022
2022

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 30 publications
(26 citation statements)
references
References 21 publications
1
21
0
4
Order By: Relevance
“…In a sample of patients under dialysis, we found that IN-TERMED scores were associated with low quality of life at 1-year follow-up [24], which in turn was unrelated to baseline parameters of the severity of illness. In multiple sclerosis outpatients, INTERMED scores were associated with measures of disability and with the number of disciplines proposed in the multidisciplinary treatment plan [25]. These data confirm the ability of the INTERMED to detect patients at risk and to predict clinical outcomes in several patient samples.…”
Section: Validity Of the Intermedsupporting
confidence: 76%
“…In a sample of patients under dialysis, we found that IN-TERMED scores were associated with low quality of life at 1-year follow-up [24], which in turn was unrelated to baseline parameters of the severity of illness. In multiple sclerosis outpatients, INTERMED scores were associated with measures of disability and with the number of disciplines proposed in the multidisciplinary treatment plan [25]. These data confirm the ability of the INTERMED to detect patients at risk and to predict clinical outcomes in several patient samples.…”
Section: Validity Of the Intermedsupporting
confidence: 76%
“…As measured by the INTERMED method, complexity indicates a need for multidisciplinary and integrated treatment. This has been demonstrated for different patient groups [1][5]. Compelling evidence suggests that biopsychosocial case complexity influences patient health outcomes [6], [7], health care use [8], patient management [9], [10] and health care expenditure [11].…”
Section: Introductionmentioning
confidence: 93%
“…During the initial consultation (month 0), clinicians used the INTERMED, a validated observer-rated instrument for assessing case complexity and health care needs using a biopsychosocial model, [11][12][13][14][15][16][17][18] to stratify patients into either the regular-intensity (score of 0 through 20) or high-intensity (score of 21 or more) program. For the regular-intensity program, consultations were conducted intermittently at enrollment (month 0) and months 1, 4, and 6.…”
Section: Program Evaluation Design and Samplementioning
confidence: 99%